Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Globus Medical, which has a market cap of $11.9bn, will buy all Nevro ... stimulator systems, for example, gained access to a wider market after winning FDA approval for non-surgical back pain ...

Nevro (NVRO) shares ended the last trading session ... This maker of an electrical implant that treats leg and back pain is expected to post quarterly loss of $0.79 per share in its upcoming ...